1.
|
Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 10-0933, NCT01229319
|
|
2.
|
Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ISD-FPT-01-2012, NCT01656226
|
|
3.
|
Phase: Phase III, Phase II Type: Prevention Status: Active Age: Over 18 Sponsor: Other Protocol IDs: N015454-00, NCT01804595
|
|
4.
|
Phase: No phase specified Type: Educational/Counseling/Training, Prevention Status: Active Age: Adult Sponsor: NCI Protocol IDs: RIH-1050258954A1, RIH-0348-03, NCT00295906
|
|
5.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: SKIN0010, SU-10272011-8570, 22207, NCI-2012-00043, NCT01477463
|
|
6.
|
Phase: No phase specified Type: Prevention Status: Approved-not yet active Age: 18 to 85 Sponsor: Other Protocol IDs: STU00058220, NCT01646099
|
|
7.
|
Phase: No phase specified Type: Prevention Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: BSMMU-003-CT, NCT01731756
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: BSMMU-002-CT, NCT01735097
|